Used in pharmaceutical synthesis as a chiral intermediate for developing protease inhibitors, particularly in the treatment of viral infections such as hepatitis C. Its stereochemistry enables high selectivity in drug design, improving efficacy and reducing side effects. Also employed in the development of enzyme inhibitors due to its ability to mimic transition states in peptide hydrolysis. Commonly utilized in research settings for optimizing metabolic stability and bioavailability in small-molecule therapeutics.